Held 24 to 26 October 2014 in London.

The survey was conducted as part of the pre-conference research created for 7th Annual Development IP Strategies for Crystalline Forms, held 24 to 26 October 2014 in London.

With regard to the most important word in regions, Europe was named in the patent strategies of 83.3 %, while the U.S. Proved to be a major concern for 33.3 % of the respondents is an important geographic region. Asia was cited as a priority by only 16.7 % of the participants in the study.

For Crystalline Forms ReportPharma IQ has just published the results of an industry-wide IP Crystals recently conducted recently conducted among 6,000 patent specialists with more than 65 percent of those directly responsible for application development.AUTHOR CONTACT: Giulio Maria Pasinetti Mount Sinai School of Medicine, New York, in New York City,the wide hearted not always good news beingheart wall thickening to heart failure and is a major cause of death. Currently show no medication able to cardiac hypertrophy, in part reversed, because our understanding which molecular mechanisms that can be undone by cardiac hypertrophy, is limited. But now, latest research results in mice by Cam Patterson and colleagues on University of North Carolina, Chapel Hill a mechanism for the protein interferes with atrogin-1 routes to promote the cardiac hypertrophy identifying.

TITLE: IL-17 – dependent cellular immunity collagen type V. Predisposes to bronchiolitis in human lung transplant obliterative.